A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol
- 1 September 1993
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 169 (3) , 526-530
- https://doi.org/10.1016/0002-9378(93)90613-n
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndromeAmerican Journal of Obstetrics and Gynecology, 1992
- Placental insufficiency as a possible cause of low maternal serum human chorionic gonadotropin and low maternal serum unconjugated estriol levels in triploidyAmerican Journal of Obstetrics and Gynecology, 1992
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- The efficacy of maternal age screening for Down's syndrome in WessexPrenatal Diagnosis, 1991
- Prenatal screening for trisomy 18 in the second trimesterPrenatal Diagnosis, 1990
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalitiesPrenatal Diagnosis, 1987
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984